Intravenous Neonatal Central Access Safety Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-3
SponsorUniversity of Turin, Italy
About this trial
Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU).
In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated.
In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.
Eligibility criteria
Qualifiers
All patients admitted to NICU with at least one central venous catheter
Disqualifiers
Patients with peripheral venous catheter, patients with inflammatory episode at the time of enrollment
Trial design
Treatments tested in this trial
- In-line filter
Treatment groups
736 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Turin, Italy
Lead sponsor
Pall Corporation
Collaborator
Source ClinicalTrials.gov